Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Moore

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 6, 2012
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective studyThomas Walter, Anne M Horgan, Mairead McNamara, et al.
Cancer|April 7, 2005
A phase II trial of R115777, an oral farnesyl transferase inhibitor, in patients with advanced urothelial tract transitional cell carcinomaJonathan E Rosenberg, Hans von der Maase, John D Seigne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancerHelen Mackay, David Hedley, Pierre Major, et al.
The Journal of Pain|May 1, 2014
Validation of the short-form McGill pain questionnaire-2 in younger and older people with cancer painLynn R Gauthier, Alycia Young, Robert H Dworkin, et al.
European Urology|July 7, 2009
No role for routine chest radiography in stage I seminoma surveillanceShaun Tolan, Danny Vesprini, Michael A S Jewett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based ChemotherapySharlene Gill, Yoo-Joung Ko, Christine Cripps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinomaEric Van Cutsem, Emilio Bajetta, Juan Valle, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2003
Appropriate radiation volume for stage IIA/B testicular seminomaPeter W M Chung, Padraig R Warde, Tony Panzarella, et al.
Urologic Oncology|July 14, 2007
Long-term outcome of radiation-based conservation therapy for invasive bladder cancerPeter W M Chung, Robert G Bristow, Michael F Milosevic, et al.
European Urology|August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular CancerMadhur Nayan, Michael A S Jewett, Ali Hosni, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|September 6, 2012
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective studyThomas Walter, Anne M Horgan, Mairead McNamara, et al.
Cancer|April 7, 2005
A phase II trial of R115777, an oral farnesyl transferase inhibitor, in patients with advanced urothelial tract transitional cell carcinomaJonathan E Rosenberg, Hans von der Maase, John D Seigne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancerHelen Mackay, David Hedley, Pierre Major, et al.
The Journal of Pain|May 1, 2014
Validation of the short-form McGill pain questionnaire-2 in younger and older people with cancer painLynn R Gauthier, Alycia Young, Robert H Dworkin, et al.
European Urology|July 7, 2009
No role for routine chest radiography in stage I seminoma surveillanceShaun Tolan, Danny Vesprini, Michael A S Jewett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based ChemotherapySharlene Gill, Yoo-Joung Ko, Christine Cripps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Randomized, placebo-controlled, phase III study of oxaliplatin, fluorouracil, and leucovorin with or without PTK787/ZK 222584 in patients with previously treated metastatic colorectal adenocarcinomaEric Van Cutsem, Emilio Bajetta, Juan Valle, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2003
Appropriate radiation volume for stage IIA/B testicular seminomaPeter W M Chung, Padraig R Warde, Tony Panzarella, et al.
Urologic Oncology|July 14, 2007
Long-term outcome of radiation-based conservation therapy for invasive bladder cancerPeter W M Chung, Robert G Bristow, Michael F Milosevic, et al.
European Urology|August 17, 2016
Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular CancerMadhur Nayan, Michael A S Jewett, Ali Hosni, et al.
Pageof 13